Angiotensin II blockade is associated with decreased plasma leukocyte adhesion molecule levels in diabetic nephropathy

Diabetes Care. 2000 Jul;23(7):1031-2. doi: 10.2337/diacare.23.7.1031.
No abstract available

Publication types

  • Clinical Trial
  • Controlled Clinical Trial
  • Letter

MeSH terms

  • Angiotensin Receptor Antagonists
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
  • Antihypertensive Agents / therapeutic use*
  • Blood Pressure / drug effects
  • C-Reactive Protein / analysis
  • Cross-Over Studies
  • Diabetes Mellitus, Type 1 / physiopathology*
  • Diabetic Nephropathies / blood*
  • Diabetic Nephropathies / drug therapy*
  • Diabetic Nephropathies / immunology
  • E-Selectin / blood
  • Glomerular Filtration Rate / drug effects
  • Humans
  • Intercellular Adhesion Molecule-1 / blood*
  • Losartan / therapeutic use*
  • Placebos
  • Receptor, Angiotensin, Type 1
  • Receptor, Angiotensin, Type 2
  • Reference Values
  • Vascular Cell Adhesion Molecule-1 / blood*
  • von Willebrand Factor / analysis

Substances

  • Angiotensin Receptor Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Antihypertensive Agents
  • E-Selectin
  • Placebos
  • Receptor, Angiotensin, Type 1
  • Receptor, Angiotensin, Type 2
  • Vascular Cell Adhesion Molecule-1
  • von Willebrand Factor
  • Intercellular Adhesion Molecule-1
  • C-Reactive Protein
  • Losartan